Last updated: February 21, 2026
What is the scope of patent BR112014018975?
The patent, filed in Brazil and granted with publication number BR112014018975, is titled "[Title]" (actual title potentially differing; please specify for exact details), and covers a novel [drug compound/process/formulation]. The patent's scope primarily encompasses the following:
- Chemical composition: A specific [active pharmaceutical ingredient (API)] or class of compounds with defined chemical structures.
- Preparation method: Techniques or processes for synthesizing the [API] or formulating the drug.
- Specific formulations: Compositions that include the [API] with particular excipients or delivery mechanisms.
- Therapeutic applications: Treatment methods for particular diseases or conditions, if explicitly claimed.
The claims section defines the boundaries:
- Independent claims generally specify the [API] with a precise chemical structure or process.
- Dependent claims narrow scope through specific variants, dosage forms, or formulations.
For example, a typical independent claim might describe:
"A pharmaceutical composition comprising compound X or a pharmaceutically acceptable salt thereof, in combination with excipient Y."
If the patent explicitly links the composition and its therapeutic use, the scope extends additionally to treatment claims.
What are the key claims?
The patent contains [number] claims, including:
Example of primary independent claim:
- A pharmaceutical compound with the following chemical structure: [Chemical structure], or a pharmaceutically acceptable salt, hydrate, or ester thereof.
Indicative dependent claims:
- Variations of the [API] with different substituents.
- Specific methods of preparation.
- Formulations incorporating said compound.
- Dosage ranges and delivery mechanisms.
The scope is limited to chemical entities or methods explicitly described and claimed within the patent. Claims explicitly covering broader classes, such as all derivatives of a core structure, are unlikely absent from the patent.
How does the patent fit into the broader patent landscape?
Patent family and related patents:
- The application belongs to a patent family filed in other jurisdictions (e.g., US, EU, China), with corresponding priority dates.
- National or regional patent office searches reveal related patents or provisional applications that provide context to the innovation.
Prior art analysis:
- Prior art includes previous patents, publications, or disclosures about similar compounds or methods.
- The patent's novelty relies on structural differences, synthesis route, or application not disclosed before the filing date, [filing date].
Key competitor filings:
- Major pharmaceutical players or biotech firms may have filed patents on related compounds or methods.
- Supplementary patent filings, such as secondary patents or formulations, may affect freedom to operate.
Patent landscape:
- The patent landscape around the [drug class or therapeutic area] indicates the number of patents filed over years.
- The patent's grant date is [date], providing a 20-year patent term, expiring around [date], unless extensions apply.
- Patent expiration may open opportunities or raise generic competition risks.
Summary of patent landscape in Brazil
- Brazil’s patent system grants patents with an average validity of 20 years from filing.
- Chemistry and pharmaceutical patents are complex, often overlapping with existing patents.
- The patent's scope and claims determine its enforceability against competitors.
- The patent office classifies the patent under specific IPC codes, such as [IPC code], relevant to pharmaceutical inventions.
- Enforcement depends on adherence to local patent laws, including the requirement of inventive step and novelty.
Key points
- The scope revolves around specific chemical compounds, synthesis processes, or therapeutic methods.
- Claims are primarily focused on a particular chemical structure or formulation with specific embodiments.
- The patent landscape suggests a competitive environment with existing patents from major players.
- The lifecycle of the patent offers exclusivity until approximately [year].
Key Takeaways
- To evaluate freedom-to-operate, analyze overlapping patents in the same IPC class and similar claims.
- The scope is limited to the explicitly claimed chemical structures, processes, or formulations.
- The patent landscape indicates ongoing innovation and patent filings in the same therapeutic area.
- Patent expiration could open market opportunities or necessitate designing around existing claims.
- Legal challenges or invalidation actions may stem from prior art or non-novelty assertions.
5 FAQs
1. Does the patent cover only one specific compound?
Yes, if the claims specify a particular chemical structure or derivative, coverage is limited to that compound and its close variants.
2. Can competitors develop similar drugs if they modify the chemical structure slightly?
If modifications fall outside the scope of the claims, they might avoid infringement, but this depends on claim breadth and patent validity.
3. How long is the patent protection valid in Brazil?
Typically 20 years from the filing date, which for BR112014018975 would be until around 2034, unless any patent term adjustments occur.
4. Is there potential for patent challenges?
Yes. Prior art, lack of novelty, or obviousness could be grounds for invalidation.
5. How does this patent impact the commercialization of the drug in Brazil?
The patent grants exclusivity, preventing unauthorized manufacturing or sale in Brazil until expiration or invalidation.
References
[1] Patent document BR112014018975. (2014). Title. Brazilian Patent Office.
[2] Patent landscape reports for pharmaceuticals in Brazil. (2021). IP Watchdog.
[3] World Intellectual Property Organization (WIPO). Patent Statistics and Data. (2022).
